03:37 PM EST - Acerus Pharmaceuticals Corporation : Announced the signing of an agreement granting Eu Hwa Pte LTD. (EU) the exclusive right to market NATESTO® in Thailand, Malaysia/Brunei, Singapore, Vietnam, Philippines, Hong Kong/Macau and one other small South East Asian country. EU is a subsidiary of one of Taiwan’s largest pharmaceutical companies, which has more than 800 employees worldwide as well as more than 300 dedicated pharmaceutical commercial employees with expertise across multiple therapeutic areas in South East Asia, including endocrinology and urology. Acerus Pharmaceuticals Corporation
shares T.ASP are trading up $0.01 at $0.12.
